TREATMENT TAILORING IN EPITHELIAL ADVANCED OVARIAN CANCER: SURVIVAL RESULTS IN NAVARRE

被引：0
|
作者：
Tauste Rubio, C. M. [1 ]
Zabaleta Jurio, J. [2 ]
Aguirre Gorospe, S. [2 ]
Barrenetxea Arrinda, J. [2 ]
Gaston Moreno, B. [2 ]
Muruzabal Torquemada, J. C. [2 ]
机构：
[1] Complejo Hosp Navarra, Gynaecol Oncol, Osasunbidea Navarre Hlth Serv, Pamplona, Spain
[2] Complejo Hosp Navarra, Pamplona, Spain
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2019年 / 29卷
关键词：
D O I：
10.1136/ijgc-2019-ESGO.1041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP997
引用
收藏
页码：A526 / A527
页数：3
相关论文
共 50 条
  • [41] EFFECT OF SURGICAL PARADIGM CHANGE ON OVERALL SURVIVAL IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER
    Norppa, N.
    Saarelainen, S.
    Staff, S.
    Auranen, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A199 - A199
  • [42] Clinicopathologic factors associated with short-term survival in advanced epithelial ovarian cancer
    Zhou, Shuwei
    Liu, Yao
    Yin, Wanchun
    Liao, Qianqian
    Quan, Quan
    Mu, Xiaoling
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (06) : 2396 - 2404
  • [43] THE IMPACT OF CHARLSON'S COMORBIDITY INDEX IN OVERALL SURVIVAL FOR ADVANCED EPITHELIAL OVARIAN CANCER
    Nunes, R.
    Mantoan, H.
    Goncalves, B.
    Faloppa, C.
    Kumagai, L.
    Badiglian-Filho, L.
    de Brot, L.
    da Costa, A.
    Baiocchi, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A119 - A119
  • [44] High vimentin expression is predictive of poorer survival in advanced stage epithelial ovarian cancer
    Full, Katherine
    Blansit, Kevin
    Lin, Nichole Young
    Fuh, Jen
    Yeaton-Massey, Amanda
    Longacre, Terry
    Owen, T.
    Chan, John K.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 399 - 400
  • [45] Neoadjuvant chemotherapy in advanced epithelial ovarian cancer by histology: A SEER based survival analysis
    Liu, Yuexi
    Ni, Meng
    Huang, Fanfan
    Gu, Qiuying
    Xiao, Yao
    Du, Xinyue
    MEDICINE, 2023, 102 (04) : E32774
  • [46] Clinicopathologic factors associated with long-term survival in advanced epithelial ovarian cancer
    Lee, A. Jin
    Son, Joo-Hyuk
    Choi, Chel Hun
    Kim, Hee Seung
    Lee, Sung Jong
    Lee, Shin Wha
    Lim, Myong Cheol
    Chang, Suk-Joon
    Shim, Seung-Hyuk
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A203 - A203
  • [47] State of results of HIPEC for epithelial ovarian cancer in the primary treatment or for relapse
    Classe, Jean -Marc
    Frenel, Jean-Sebastien
    Berton, Dominique
    Gladieff, Laurence
    Ferron, Gwenael
    Lecuru, Fabrice
    Bourgin, Charlotte
    Narducci, Fabrice
    Loaec, Cecile
    BULLETIN DU CANCER, 2024, 111 (03) : 261 - 266
  • [48] Conservative treatment in epithelial ovarian cancer:: results of a French multicenter study
    Morice, P.
    Leblanc, E.
    Rey, A.
    Baron, M.
    Querleu, D.
    Blanchot, J.
    Duvillard, P.
    Lhomme, C.
    Classe, J. M.
    Bonnier, P.
    EJC SUPPLEMENTS, 2005, 3 (02): : 268 - 269
  • [49] Sociodemographic Disparities in Advanced Ovarian Cancer Survival and Adherence to Treatment Guidelines
    Bristow, Robert E.
    Chang, Jenny
    Ziogas, Argyrios
    Campos, Belinda
    Chavez, Leo R.
    Anton-Culver, Hoda
    OBSTETRICS AND GYNECOLOGY, 2015, 125 (04): : 833 - 842
  • [50] Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study
    Elzarkaa, Alaa A.
    Shaalan, Waleed
    Elemam, Doaa
    Mansour, Hassan
    Melis, Mahmoud
    Malik, Eduard
    Soliman, Amr A.
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (04)
12345